Top Links

Articles Related to chemotherapy

Primary Osteosarcoma of the Nasal Fossa: An Exceptional Presentation

Sarcomas of the head and neck are very rare accounting for approximately 1% of all head and neck neoplasms. Primary osteosarcomas of the nasal cavity are less than 0.5% of the osteosarcomas occur in this location. Because of the rarity of this presentation, we report a case of a 54 year old male with primary osteosarcoma arising de novo from the nasal cavity, presented with left epistaxis and bilateral nasal obstruction.
View complete article: PDF  |  Full-text

The Use of Cardiac Resynchronization Therapy in Cancer Patients with Heart Failure

Investigate the use of cardiac resynchronization therapy (CRT) in cancer patients with heart failure (HF); assess factors associated with ischemic and non-ischemic HF. Many newer cancer therapies are cardiotoxic; thus, the incidence of HF has been increasing in this high-risk patient population. CRT has beneficial effects on morbidity, mortality, and left ventricular function in patients with non-ischemic cardiomyopathy, yet cancer patients and survivors who develop severe HF and are eligible for CRT often does not receive it.
View complete article: PDF  |  Full-text

Evaluating the Effect of Oprelvekin on Cardiac Repolarization in Subjects with Chemotherapy-Induced Thrombocytopenia: An Observational Chart Review of a Phase 2 Clinical Trial in Laredo, Texas

This study tested for the cardiac effects of Oprelvekin, recombinant human interleukin-11, a thrombopoietic growth factor, in patients afflicted with chemotherapy-induced thrombocytopenia (platelet count<50,000 cells/ul). Chart-reviews of patients fulfilling the inclusion criteria of: 18-75 yrs of age, non-myeloid malignancy, with adequate hematologic, hepatic and renal parameters and normal electrocardiograms that were enrolled in this phase 2 trial were analyzed. Patients of child-bearing potential agreed to be on a reliable form of birth control for the duration of the study. Results on 4 patients suggest that Oprelvekin does not cause atrial nor ventricular arrhythmia, a rare severe cardiac side effect, in treating patients with chemotherapy-induced thrombocytopenia.
View complete article: PDF  |  Full-text

Palmoplantar Malignant Melanoma in the Brazzaville University Hospital

Palmoplantar Malignant Melanoma (PPMM) is a tumor that arises from the melanocytes of the palmoplantar location. It is usually curable when treated surgically if diagnosed early. Objective: To assess the clinical presentation and treatment outcome of PPMM in Brazzaville Patients and Methods: This is a cross sectional study of thirteen years (January 1998-December 2011). 121 patients with PPMM who received the 3 treatment types were included: Surgery, chemotherapy and combination of surgery and chemotherapy.
View complete article: PDF  |  Full-text

Challenges in the Pharmacological Management of Non Hodgkin’s Lymphoma in Children in the Maintenance Phase of Therapy at Kenyatta National Hospital

Non Hodgkin’s lymphoma is an extremely chemo sensitive with a five year event free survival of greater than 90% in developed countries and a one year survival rate of 40-50% in developing countries.
View complete article: PDF  |  Full-text

Retinoblastoma: A Retrospective Study of 27 Cases in University Hospital of Lubumbashi-RDC

We conducted a retrospective study on 27children with retinoblastoma in the Lubumbashi University Hospital between January 2008 and October 2012. Al cases were diagnosis clinically and 11 cases were confirmed by histology.
View complete article: PDF  |  Full-text

A Rare Case of Small Cell Neuroendocrine Carcinoma of the Nasal Cavity and Paranasal Sinuses

Neuroendocrine neoplasms are defined as epithelial neoplasms with predominant neuroendocrine differentiation. They are most commonly found in the gastrointestinal tract and respiratory system.
View complete article: PDF  |  Full-text

HCV in Lymphoid Neoplasms

HBV carrier cases
View complete article: PDF  |  Full-text

Inguinal Lymph Node Squamous Cell Carcinoma of Unknown Primary Site: A Case Report

Carcinoma of unknown primary site (CUP) is a heterogeneous group of malignancies associated with dismal prognosis. Although majority of the patients present with disseminated disease, some of them do present with disease limited to the lymph nodes.
View complete article: PDF  |  Full-text

Effect of Neoadjuvant Chemoradiotherapy on Pathologic Stage and Survival in Patients with Locally Advanced Esophageal Cancer

The treatment of resectable stages of esophageal cancer often involves pre-operative concurrent chemoradiotherapy. This study aims to evaluate the effect of cisplatin/5-fluorouracil (5-FU)-based neoadjuvant chemoradiotherapy on pathologic stage and survival in patients with locally advanced esophageal cancer.
View complete article: PDF  |  Full-text

Extramedullary Plasmacytoma of the Nasal Cavity: Case Report

The extramedullary plasmacytoma is a rare malignant proliferation clone secreting a monoclonal immunoglobulin. The location to the upper aerodigestive tract represents 80-90% of cases.
View complete article: PDF  |  Full-text

Gastroesophageal Cancer: Prognostic Factors and Treatment Results

The study presents the remote results of surgical treatment of 329 patients with cancer of gastroesophageal localization. Three 3-year survival rate is 37.1%, the 5-year survival rate is 26.2%. Prognosis after the surgery depends primarily on the extent of the tumour spread.
View complete article: PDF  |  Full-text

Age Adjusted Charlson Comorbidity Index: Predictor of 90-Day Mortality after Radical Cystectomy

To evaluate the impact of age adjusted Charlson’s comorbidity index (ACCI) in predicting 90-day mortality in patients undergoing radical cystectomy for Muscle Invasive Bladder Cancer (MIBC) in a low volume center.
View complete article: PDF  |  Full-text

Hepatic Dysfunction as Presenting Manifestation of Hodgkin’s lymphoma

Hepatic dysfunction is rarely the presenting feature of malignancy, however it is important to recognize early on as the quick institution of chemotherapy could potentially reverse the liver disease.
View complete article: PDF  |  Full-text

Development of the Analytical Model for the Assessment of the Efficiencies of Different Therapeutic Modalities in Leukemia

Different therapeutic regimes like chemotherapy, cytokine based immunotherapy and/or stem cell transplantation are generally be the suggested options for treatment of leukemia. However, the selection of the best therapeutic strategy for an individual patient remains uncertain till now
View complete article: PDF  |  Full-text


Editorial Board Members Related to chemotherapy

Shi J. Liu

Professor
Department of Pharmaceutical Sciences
University of Arkansas for Medical Sciences
United States

Lili Chen

Associate Professor
Department of Radiation Oncology
Fox Chase Cancer Center
United States

PATRICIA A. KRUK

Professor
Department of Obstetrics and Gynecology
USF Morsani College of Medicine
University of South Florida
United States
Submit Manuscript